The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Mirum Pharmaceuticals Inc (NASDAQ: MIRM) closed at $25.83 in the last session, up 3.15% from day before closing price of $25.04. In other words, the price has increased by $3.15 from its previous closing price. On the day, 0.63 million shares were traded. MIRM stock price reached its highest trading level at $26.85 during the session, while it also had its lowest trading level at $24.67.
Ratios:
We take a closer look at MIRM’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.47 and its Current Ratio is at 3.68. In the meantime, Its Debt-to-Equity ratio is 1.31 whereas as Long-Term Debt/Eq ratio is at 1.31.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on April 17, 2024, initiated with a Buy rating and assigned the stock a target price of $48.
On December 18, 2023, H.C. Wainwright reiterated its Buy rating and also upped its target price recommendation from $60 to $58.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 27 ’24 when BJERKHOLT ERIC bought 2,000 shares for $24.80 per share. The transaction valued at 49,600 led to the insider holds 14,000 shares of the business.
Radovich Peter sold 4,303 shares of MIRM for $111,017 on Mar 25 ’24. The PRESIDENT AND COO now owns 29,013 shares after completing the transaction at $25.80 per share. On Mar 18 ’24, another insider, BJERKHOLT ERIC, who serves as the CHIEF FINANCIAL OFFICER of the company, bought 2,000 shares for $25.80 each. As a result, the insider paid 51,600 and bolstered with 12,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MIRM now has a Market Capitalization of 1217445376 and an Enterprise Value of 1198779392. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.43 while its Price-to-Book (P/B) ratio in mrq is 5.18. Its current Enterprise Value per Revenue stands at 6.432 whereas that against EBITDA is -12.192.
Stock Price History:
Over the past 52 weeks, MIRM has reached a high of $35.56, while it has fallen to a 52-week low of $23.14. The 50-Day Moving Average of the stock is -0.61%, while the 200-Day Moving Average is calculated to be -8.00%.
Shares Statistics:
According to the various share statistics, MIRM traded on average about 490.50K shares per day over the past 3-months and 428560 shares per day over the past 10 days. A total of 46.72M shares are outstanding, with a floating share count of 37.20M. Insiders hold about 21.06% of the company’s shares, while institutions hold 90.89% stake in the company. Shares short for MIRM as of 1713139200 were 8575418 with a Short Ratio of 17.48, compared to 1710460800 on 8137605. Therefore, it implies a Short% of Shares Outstanding of 8575418 and a Short% of Float of 21.190001.
